You are here

Article Text

Article menu

Download PDFPDF

PostScript
Correspondence
Utility of cytopathology in diagnosis and molecular testing of lung cancer
Free
  1. Sakinah A Thiryayi1,
  2. Durgesh N Rana1,
  3. Mark Woodhead2
  1. 1Department of Cytopathology, Manchester Royal Infirmary, Manchester, UK
  2. 2Department of Respiratory Medicine, Manchester Royal Infirmary, Manchester, UK
  1. Correspondence to Sakinah A Thiryayi, Department of Cytopathology, 1st Floor Clinical Sciences Building 2, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL, UK; sakinah.a.t{at}hotmail.co.uk

https://doi.org/10.1136/thoraxjnl-2011-200559

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We read with interest the editorial by Booton et al1 on advances in the treatment and diagnosis of non-small cell lung cancer. Recently published best practice guidelines for pathology recommend the provision of as precise a diagnosis as possible, with optimisation of specimen use.2 We advocate the utility of cytopathology in this regard and share our experience of the diagnostic potential and the range of ancillary tests possible on respiratory-related cytology specimens.

    During a 20-month period (1 September 2009 to 30 April 2011), 227 …

    View Full Text